Pneumonia Complicating the Acute Respiratory Distress Syndrome

ABSTRACT

Ventilator-associated pneumonia (VAP) complicating the course of acute respiratory distress syndrome (ARDS) is one of the most challenging diagnostic and treatment dilemmas in critical care medicine. The VAP incidence rate ranges from 37 to 60% in ARDS patients, significantly greater than for other causes of respiratory failure. Although the normal risk factors for VAP are the same in ARDS patients, multiple aspects of the underlying disease and its management increase the risk compared with non-ARDS patients. Multiple mimics of the clinical symptoms and signs make the clinical diagnosis of VAP very nonspecific in the setting of ARDS. The multilobar but predominantly lower lobe pattern of pneumonia in ARDS makes use of quantitative cultures of lower respiratory secretions (sampled by various techniques) very accurate to confirm the presence of pneumonia. VAP in ARDS patients is usually late-onset and therefore caused by highly antibiotic-resistant microorganisms. Somewhat surprisingly, the mortality of ARDS patients with VAP is not significantly greater than that of ARDS patients without VAP, although subsequent duration of mechanical ventilation is consistently prolonged in patients with VAP.

KEYWORDS

Acute respiratory distress syndrome - ventilator-associated pneumonia - fibroproliferation

REFERENCES

• 1 Andrews C P, Coalson J J, Smith J D, Johanson W GJ. Diagnosis of nosocomial bacterial pneumonia in acute, diffuse lung injury.  Chest . 1981;  80 254-258
• 2 Bell R C, Coalson J J, Smith J D, Johanson W GJ. Multiple organ system failure and infection in adult respiratory distress syndrome.  Ann Intern Med . 1983;  99 293-298
• 3 Montgomery A B, Stager M A, Carrico C J, Hudson L D. Causes of mortality in patients with the adult respiratory distress syndrome.  Am Rev Respir Dis . 1985;  132 485-489
• 4 Chastre J, Trouillet J-L, Vuagnat A. Nosocomial pneumonia in patients with acute respiratory distress syndrome.  Am J Respir Crit Care Med . 1998;  157 1165-1172
• 5 Markowicz P, Wolff M, Djedaini K. Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome: incidence, prognosis, and risk factors. ARDS Study Group.  Am J Respir Crit Care Med . 2000;  161 1942-1948
• 6 Meduri G U, Reddy R C, Stanley T, El Zeky F. Pneumonia in acute respiratory distress syndrome: a prospective evaluation of bilateral bronchoscopic sampling.  Am J Respir Crit Care Med . 1998;  158 870-875
• 7 Delclaux C, Roupie E, Blot F. Lower respiratory tract colonization and infection during severe acute respiratory distress syndrome: incidence and diagnosis.  Am J Respir Crit Care Med . 1997;  156 1092-1098
• 8 George D L, Falk P S, Wunderink R G. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling.  Am J Respir Crit Care Med . 1998;  158 1839-1847
• 9 Cook D J, Kollef M H. Risk factors for ICU-acquired pneumonia.  JAMA . 1998;  279 1605-1606
• 10 Johanson W G, Pierce A K, Sanford J P. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli.  N Engl J Med . 1969;  21 1137-1140
• 11 de Latorre J F, Pont T, Ferrer A. Pattern of tracheal colonization during mechanical ventilation.  Am J Respir Crit Care Med . 1995;  152 1028-1033
• 12 Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000 342: 1301-1308
• 13 Stewart T E, Meade M O, Cook D J. Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group.  N Engl J Med . 1998;  338 355-361
• 14 Torres A, Serra-Batles J, Ros E. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position.  Ann Intern Med . 1992;  116 540-543
• 15 Drakulovic M B, Torres A, Bauer T T. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial.  Lancet . 1999;  354 1851-1858
• 16 Gattinoni L, Tognoni G, Pesenti A. Effect of prone positioning on the survival of patients with acute respiratory failure.  N Engl J Med . 2001;  345 568-573
• 17 Atkinson S, Sieffert E, Bihari D, Guy's Hospital Intensive Care Group. A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill.  Crit Care Med . 1998;  26 1164-1172
• 18 Meduri G U, Belenchia J M, Estes R G. Fibroproliferative phase of ARDS: clinical findings and effects of corticosteroids.  Chest . 1991;  100 943-954
• 19 Hebert P C, Wells G, Blajchman M A. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.  N Engl J Med . 1999;  340 409-417
• 20 Headley A S, Tolley E, Meduri G U. Infections and the inflammatory response in acute respiratory distress syndrome.  Chest . 1997;  111 1306-1321
• 21 Bone R C. Sir Isaac Newton, sepsis, SIRS, and CARS.  Crit Care Med . 1996;  24 1125-1128
• 22 Bone R C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS).  Ann Intern Med . 1996;  125 680-687
• 23 O'Mahony J B, Palder S B, Wood J J. Depression of cellular immunity after multiple trauma in the absence of sepsis.  J Trauma . 1984;  24 869-875
• 24 Asadullah K, Woiciechowsky C, Docke W D. Immunodepression following neurosurgical procedures.  Crit Care Med . 1995;  23 1976-1983
• 25 Schinkel C, Sendtner R, Zimmer S, Faist E. Functional analysis of monocyte subsets in surgical sepsis.  J Trauma . 1998;  44 743-748
• 26 Winer-Muram H T, Rubin S A, Ellis J V. Pneumonia and ARDS in patients receiving mechanical ventilation: diagnostic accuracy of chest radiography.  Radiology . 1993;  188 479-485
• 27 Meduri G U, Mauldin G L, Wunderink R G. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia.  Chest . 1994;  106 221-225
• 28 George D L, Falk P S, Meduri G U. Nosocomial sinusitis in patients in the medical intensive care unit: a prospective epidemiological study.  Clin Infect Dis . 1998;  27 463-470
• 29 Ashbaugh D G, Maier R V. Idiopathic pulmonary fibrosis in adult respiratory distress syndrome.  Arch Surg . 1985;  120 530-535
• 30 Hooper R G, Kearl R A. Established ARDS treated with a sustained course of adrenocortical steroids.  Chest . 1990;  97 138-143
• 31 Wunderink R G, Woldenberg L S, Zeiss J. Radiologic diagnosis of autopsy-proven ventilator-associated pneumonia.  Chest . 1992;  101 458-463
• 32 Marquette C H, Copin M C, Wallet F. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard.  Am J Respir Crit Care Med . 1995;  151 1878-1888
• 33 Rouby J J, De Lassale M E, Poete P. Nosocomial bronchopneumonia in the critically ill: histologic and bacteriologic aspects.  Am Rev Respir Dis . 1992;  148 1059-1066
• 34 Sanchez-Nieto J M, Torres A, Garcia-Cordoba F. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study.  Am J Respir Crit Care Med . 1998;  157 371-376
• 35 Kollef M H, Bock K R, Richards R D, Hearns M L. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia.  Ann Intern Med . 1995;  122 743-748
• 36 Fagon J Y, Chastre J, Wolff M. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia: a randomized trial.  Ann Intern Med . 2000;  132 621-630
• 37 Cook D J, Walter S D, Cook R J. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients.  Ann Intern Med . 1998;  129 433-440
• 38 Sirvent J M, Torres A, El Ebiary M. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma.  Am J Respir Crit Care Med . 1997;  155 1729-1734
• 39 Rello J, Sa-Borges M, Correa H, Leal S R, Baraibar J. Variations in etiology of ventilator-associated pneumonia across four treatment sites: implications for antimicrobial prescribing practices.  Am J Respir Crit Care Med . 1999;  160 608-613
• 40 Trouillet J-L, Chastre J, Vuagnat A. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.  Am J Respir Crit Care Med . 1998;  157 531-539
• 41 Combes A, Figliolini C, Trouillet J-L. Is it possible to predict infection recurrence after 8 days of treatment of ventilator-associated pneumonia?.  Am J Respir Crit Care Med . 2002;  165 A240
• 42 Fink M P, Snydman D R, Niederman M S. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.  Antimicrob Agents Chemother . 1994;  38 547-557
• 43 Brun-Buisson C, Sollet J P, Schweich H, Briere S, Petit C. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group.  Clin Infect Dis . 1998;  26 346-354
• 44 Fagon J, Patrick H, Haas D W. Treatment of gram-positive nosocomial pneumonia: prospective randomized comparison of quinupristin/dalfopristin versus vancomycin. Nosocomial Pneumonia Group.  Am J Respir Crit Care Med . 2000;  161 753-762
• 45 Rubinstein E, Cammarata S, Oliphant T, Wunderink R. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.  Clin Infect Dis . 2001;  32 402-412
• 46 Silver D R, Cohen I L, Weinberg P F. Recurrent Pseudomonas aeruginosa pneumonia in an intensive care unit.  Chest . 1992;  101 194-198
• 47 Rello J, Mariscal D, March F. Recurrent Pseudomonas aeruginosa pneumonia in ventilated patients: relapse or reinfection?.  Am J Respir Crit Care Med . 1998;  157 912-916
• 48 Nahum A, Hoyt J, Schmitz L. Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs.  Crit Care Med . 1997;  25 1733-1743
• 49 Kollef M H. The prevention of ventilator-associated pneumonia.  N Engl J Med . 1999;  340 627-634
• 50 Conly J M, Hill S, Ross J, Lertzman J, Louie T J. Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates.  Am J Infect Control . 1989;  17 330-339